Lv11
14 积分 2025-12-19 加入
Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis
50分钟前
待确认
Targeted synergy for vitiligo in refractory areas: A real-world study of ruxolitinib cream combined with 308-nm excimer lamp
54分钟前
已完结
Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo
56分钟前
已完结
A meta-analysis of therapeutic trials of topical ruxolitinib cream for the treatment of vitiligo: therapeutic efficacy, safety, and implications for therapeutic practice
4天前
已完结
Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder in a Young Japanese Male Patient
5个月前
已完结
Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder
5个月前
已完结
Clinical, histopathological and prognostic features of primary cutaneous acral CD8 + T‐cell lymphoma and other dermal CD8 + cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop*
5个月前
已完结
Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder in a Young Japanese Male Patient
5个月前
已完结
Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder: A Retrospective Cohort Study of 40 Adult Patients
5个月前
已完结
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders
5个月前
已完结
皖公网安备34019202002308
